FLUAD
- Product NDC
- 70461-020
- 11-digit product format
- 704610020
- Labeler code
- 70461
- Product ID
- 70461-020_f6ed9ce4-fbb4-480c-a589-d057c73d8d96
- Type
- VACCINE
- Nonproprietary name
- influenza vaccine, adjuvanted
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Labeler
- Seqirus, Inc.
- Application
- BLA125510
- Marketing category
- BLA
- Marketing start
- 2015-11-24
- Marketing end
- 2021-07-31
- Substance
- INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 ANTIGEN (FORMALDEHYDE INACTIVATED)
- Active strength
- 15 ug/.5mL; ug/.5mL; ug/.5mL
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 125510 | Fluad | Influenza Vaccine, Adjuvanted | 351(a) | Disc | 2026-06-01 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70461-020-03 | 70461002003 | 10 SYRINGE, GLASS in 1 CARTON (70461-020-03) > .5 mL in 1 SYRINGE, GLASS (70461-020-04) | 2015-11-24 | 2021-07-31 | No | No | Current |